Insmed Incorporated
INSMNASDAQHealthcare● Active
$95.01
+$0.79(+0.84%)
Market Cap$20.6B
P/E Ratio—
52W High$212.75
52W Low$70.57
Insmed Incorporated (INSM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INSM · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.61B | $0.36B | $0.31B | $0.25B | $0.19B |
| Cost of Revenue | $0.12B | $0.09B | $0.07B | $0.06B | $0.04B |
| Gross Profit | $0.48B | $0.28B | $0.24B | $0.19B | $0.14B |
| Gross Margin %(computed) | 79.41% | 76.43% | 78.52% | 77.53% | 76.57% |
| Operating Expenses | |||||
| R&D Expenses | $0.77B | $0.60B | $0.57B | $0.40B | $0.27B |
| G&A Expenses | $0.70B | $0.46B | $0.34B | $0.27B | $0.23B |
| Total Operating Expenses | $1.66B | $1.16B | $0.95B | $0.65B | $0.52B |
| Operating Income | ($1.18B) | ($0.88B) | ($0.71B) | ($0.46B) | ($0.38B) |
| Operating Margin %(computed) | -194.04% | -241.47% | -232.51% | -186.39% | -199.03% |
| Interest Income | $0.06B | $0.05B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.08B | $0.08B | $0.08B | $0.03B | $0.04B |
| Income Before Tax | ($1.27B) | ($0.91B) | ($0.75B) | ($0.48B) | ($0.44B) |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($1.28B) | ($0.91B) | ($0.75B) | ($0.48B) | ($0.43B) |
| Net Margin %(computed) | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-6.41 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
| Wtd Avg Shares | 0.21B | 0.16B | 0.14B | 0.12B | 0.11B |
| EBITDA | ($1.17B) | ($0.82B) | ($0.66B) | ($0.45B) | ($0.38B) |
| EBITDA Margin %(computed) | -193.18% | -225.12% | -216.30% | -182.33% | -203.57% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Insmed Incorporated data
About Insmed Incorporated (INSM) Income Statement
Insmed Incorporated (INSM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, INSM reported revenue of $0.61B, gross profit of $0.48B (gross margin 79.41%), and net income of ($1.28B) — a net profit margin of -210.54%.
Frequently asked questions
INSM · 4 questionsInsmed Incorporated (INSM) reported revenue of $0.61B for 2025, up 66.7% year-over-year.
INSM revenueINSM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08